Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Camizestrant |
Trade Name | |
Synonyms | AZD-9833|AZD9 833|AZD9833|AZ-14066724 |
Drug Descriptions |
Camizestrant (AZD9833) is a selective degrader of estrogen receptor, which leads to growth inhibition of ER-positive tumors (Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020) 1024-1024). |
DrugClasses | Hormone - Anti-estrogens 25 |
CAS Registry Number | 2222844-89-3 |
NCIT ID | C160603 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Abemaciclib + Camizestrant | Abemaciclib Camizestrant | 0 | 2 |
Alpelisib + Camizestrant | Alpelisib Camizestrant | 0 | 0 |
Camizestrant | Camizestrant | 0 | 4 |
Camizestrant + Capivasertib | Camizestrant Capivasertib | 0 | 0 |
Camizestrant + Capivasertib + Palbociclib | Camizestrant Capivasertib Palbociclib | 0 | 0 |
Camizestrant + Everolimus | Camizestrant Everolimus | 0 | 1 |
Camizestrant + Itraconazole | Camizestrant Itraconazole | 0 | 0 |
Camizestrant + Palbociclib | Camizestrant Palbociclib | 0 | 3 |